Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP537081.RATFW-bHGNkd3e-B0NcMRbr2tzVbIVvcgS9OxBsVEHW3w130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537081.RATFW-bHGNkd3e-B0NcMRbr2tzVbIVvcgS9OxBsVEHW3w130_provenance.
• NP273404.RANataANhRS6xyckMLs8pat1Qi93OulCeff5vxgxRpv50130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273404.RANataANhRS6xyckMLs8pat1Qi93OulCeff5vxgxRpv50130_provenance.
• NP481161.RA570exzo9pZV9v5nJFRNJJonHkthQsgaG4Qzsy6b4xPk130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481161.RA570exzo9pZV9v5nJFRNJJonHkthQsgaG4Qzsy6b4xPk130_provenance.
• NP364701.RAKeAIF0vuucYgJH30VN93IwU92cHe0AiStVdFFFSVyRU130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP364701.RAKeAIF0vuucYgJH30VN93IwU92cHe0AiStVdFFFSVyRU130_provenance.
• NP724416.RA2mhJi0hLlaiUkx-uO_7lpqdv-WT-LkdTU2lE2PVCnco130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724416.RA2mhJi0hLlaiUkx-uO_7lpqdv-WT-LkdTU2lE2PVCnco130_provenance.
• NP630069.RAflXtelVMg-AJXPVixenoeXVGu3QCVp-gJthC0DufexI130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630069.RAflXtelVMg-AJXPVixenoeXVGu3QCVp-gJthC0DufexI130_provenance.
• NP630462.RAU4BhTu88N3hjwjq8IqaFH0KudhcUmq1c9QTyQqOVySs130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630462.RAU4BhTu88N3hjwjq8IqaFH0KudhcUmq1c9QTyQqOVySs130_provenance.
• assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP693430.RAG7Nk-TgXnO3lwc6Wqq_Meqmyzf_wuzyB1uEdDRlH4UU130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693430.RAG7Nk-TgXnO3lwc6Wqq_Meqmyzf_wuzyB1uEdDRlH4UU130_provenance.
• NP898689.RAEL7bWefQGH-CMXHNP-3WuI7go0OnwOl0jBY6_6lrMFA130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898689.RAEL7bWefQGH-CMXHNP-3WuI7go0OnwOl0jBY6_6lrMFA130_provenance.
• NP321877.RAR3ZIuj7MJeO5KQo8eqKARjXhzXepz7VHQqis53aUBcI130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321877.RAR3ZIuj7MJeO5KQo8eqKARjXhzXepz7VHQqis53aUBcI130_provenance.
• NP630076.RAPbM2Kk3FtUdPnVmnxEjzN5j0gRh8r8eCjQG79zWba6o130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630076.RAPbM2Kk3FtUdPnVmnxEjzN5j0gRh8r8eCjQG79zWba6o130_provenance.
• NP630701.RAGa9J1VE1GinDnxMzJQW8C14EYHiIWKHqQOj2ggIdOqI130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630701.RAGa9J1VE1GinDnxMzJQW8C14EYHiIWKHqQOj2ggIdOqI130_provenance.
• NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321875.RALogpelx1lbQ22fGqiDEjlH467J2xdUdWBd09ZgAe1gQ130_provenance.
• NP321878.RAPxRsNTRkiB9Ww4bJXRxd5eO4ha4GcDAVUu4lXWfnwaE130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321878.RAPxRsNTRkiB9Ww4bJXRxd5eO4ha4GcDAVUu4lXWfnwaE130_provenance.
• NP321876.RA4JtfJLpbbqphYGQ62dSVv6X0mUlZC-qvuaJnoh6O-KU130_assertion description "[Impairment of the fibrinolytic system, caused primarily by increases in the plasma levels of plasminogen activator inhibitor (PAI) type 1, are frequently found in diabetes and the insulin-resistance syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321876.RA4JtfJLpbbqphYGQ62dSVv6X0mUlZC-qvuaJnoh6O-KU130_provenance.